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a b s t r a c t
Mutations were analysed in the major capsid protein VP60 of the rabbit haemorrhagic disease virus
(RHDV), a calicivirus responsible for high mortality rates in both wild and domestic European rabbits
(Oryctolagus cuniculus). Likelihood of positive selection was estimated using the PAML software applied
to 43non-identical complete sequences of themajor capsid protein. Three codons showed signs of positive
selection (with posterior probabilities over 95%), one of them is located in the region containing the major
antigenic determinants (region E). The presence of positively selected codons (PSCs) in other regions may
suggest the existence of other antigenic regions on the major capsid protein that stimulate protective
immune responses. At all the 3 PSCs, variation contributes to putative N-glycosylation sites of the protein.European rabbit
Major capsid protein VP60
AnN-glycosylation site is deleted in the non-pathogenic strain RCV. Some of the substitutions at PSCsmay
alter the polarity and the charge of the protein with possible implications in the protein structure and
host interaction. The detection of PSCs should allow a better understanding of the interaction between
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. Introduction
Rabbit haemorrhagic disease (RHD) is a highly contagious dis-
ase, characterised by high morbidity and high mortality in both
ild and domestic adult rabbits (Oryctolagus cuniculus), whereas
abbits belowtheageof 2monthsusually survive infection (Ferreira
t al., 2004; Xu and Chen, 1989). The disease is caused by rab-
it haemorrhagic disease virus (RHDV), a member of the genus
agovirus of the family Caliciviridae (Parra and Prieto, 1990). RHDV
s a non-enveloped positive-sense single-stranded RNA virus with
genome of about 7.5 kb and a sub-genomic RNA of 2.2 kb. There
re two open reading frames (ORFs), ORF1 and ORF2. The former
ncodes a polyprotein which is cleaved into non-structural com-
onents (including a helicase, a protease and the RNA-dependent
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NA-polymerase) and the major structural protein, i.e., the capsid
P60. ORF2 encodes VP10, a basic protein present in small amounts
n virions (Thiel and Konig, 1999). The capsid protein VP60 is the
ain target of the host immune defence against RHDV, and plays
n important role in virus diagnosis and vaccine design. In common
ith other caliciviruses, the RHDV capsid is composed of two main
omains, a shell (S) domain formed by the N-terminal part of the
rotein and a protrusion (P) domain formed by the C-terminal part.
he latter can be subdivided into two subdomains, P1 and P2. Six
istinct regions (A to F) can be distinguished in the protein. The C
nd E regions are located in the exposed P2 subdomain and show
he highest degree of genetic variation (Neill, 1992).
Phylogenetic analyses based on the region E of the RHDV VP60,
lthough not consensual, showed that the phylogenetic clustering
f RHDV strains is more correlated with the year of isolation of
he strain than to the geographic location (Forrester et al., 2006;
e Gall et al., 1998; Le Gall-Reculé et al., 2003; Moss et al., 2002;
owotny et al., 1997). Recently, recombination within the VP60
ene was described (Abrantes et al., 2008; Forrester et al., 2008).
t is therefore possible that by analyzing only parts of the major
apsid protein a number of recombinant strains go undetected in
hylogenetic studies. Recombination might be one of the obstacles
o efﬁcient RHD control.
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Table 1
GenBank accession number, country of origin, strain name and year of isolation of
the 43 RHDV VP60 complete and pathogenic sequences used in the study
GenBank accession number Country strain/year
AF258618 EUA/2000
AF453761 China tp
AJ006019 UK Rainham/1993
AJ302016 France/1999
AJ303106 France/2000
AJ495856 France/2000
AJ535092 France/1995
AJ535094 France/1995
AJ969628 France/2003
AM085133 France 05-01/2005
AY269825 China/1985
AY523410 China CD
AY926883 Ireland 12/2001
AY928268 Ireland 01/2001
AY928269 Ireland
DQ069280 China/2005
DQ069281 China/2005
DQ069282 China/2005
DQ189077 Bahrain20/01
DQ189078 Saudi Arabia/1996
DQ205345 China/1997
DQ280493 China whnrh
DQ530363 China YL
DQ841708 Cuba/2004
EF363035 UK Ramsey Island/2000
EU003578 USA IN-05/2005
EU003579 Italy/1990
EU003580 South Korea/1990
EU003581 USA NY-01/2001
EU003582 USA UT-01/2001
L48547 Spain MC-89/1989
M67473 Germany FRG/1989
RHU49726 France/1988
X87607 Italy/1989
Y15424 Germany Frankfurt/1996
Y15426 Germany Meiningen/1993
Y15427 Germany Wriezen/1996
Y15440 Germany Eisenhüttenstadt/1989
Y15441 Germany Hagenow/1990
Y15442 Germany Triptis/1996
Z24757 Spain AST/1989
Z29514 France/1989
Z49271 Spain AST/1989
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Analyses of samples collected in several European countries
efore the ﬁrst documented RHDV outbreak (in China in 1984)
evealed the presence of anti-RHDV antibodies in wild and domes-
ic rabbits (Forrester et al., 2006; Moss et al., 2002; O’Keefe et
l., 1999; Rodák et al., 1990). This suggests the existence of pre-
irculating non-pathogenic virus strains related to RHDV. However,
he European rabbit populations appeared not to be entirely pro-
ected, because the ﬁrst recorded outbreaks were highly lethal.
he hypothesis that RHDV can circulate among rabbits without
ausing disease was further supported by the identiﬁcation of non-
athogenic strains (Capucci et al., 1996; Forrester et al., 2003, 2007;
heng et al., 2002). Nevertheless, to date no differences have been
ound that could explain the switch between avirulent and viru-
ent RHDV strains (Capucci et al., 1996; Forrester et al., 2003, 2007;
oss et al., 2002). Thus, knowledge of protein regions under pos-
tive selection pressure may help understanding the mechanisms
hat govern RHDV virulence, pathogenesis and RHD epidemiology.
ere we report codons of the major capsid protein VP60 that seem
o be under positive selection.
. Methods
All available complete sequences of the major capsid pro-
ein VP60 from pathogenic strains were retrieved from GenBank
the accession number, country of origin, strain name and year
f isolation of the 43 sequences used are listed in Table 1) and
ere aligned using the BioEdit software version 7.0.5.3 (Hall,
999). The following strains were excluded from the analysis
ince they were shown to be recombinants (Abrantes et al.,
008; Forrester et al., 2008): Hartmannsdorf (GenBank acces-
ion number Y15425); Czech V351 (GenBank accession number
54983); Mexico (GenBank accession number AF295785); China
984 (GenBank accession number AF402614) and France 00-08
GenBank accession number AJ319594). No evidence of recom-
ination was found for the remaining strains used (data not
hown).
In order to better understand the biology of the rabbit haemor-
hagic disease and considering the immunogenicity properties of
he capsid protein VP60, we hypothesized that substitutions in this
egion, particularly sitesunder adaptivemolecular evolution,might
lay a role in the ongoing genetic conﬂict between host and par-
site. Under neutrality, the expected ratio (ω) of non-synonymous
dN) to synonymous (dS) substitutions in a gene is one and sig-
iﬁcant deviations from this value can be interpreted as evidence
f either positive (ω >1) or purifying selection (ω <1). However,
his approach is highly conservative. Here, detection of positive
election was performed using PAML (Yang, 1997). This maximum
ikelihood (ML) method instead of averaging ω across the gene
ses codon-based models that allow heterogeneity in dN/dS among
odons in a phylogenetic context, allowing detection of recurrent
ositive selection occurring only in small portion of a gene. This
ikelihood-based evolutionary method has been successful applied
n the detection of codon-speciﬁc positive selection in viruses (e.g.
emey et al., 2005; Ross and Rodrigo, 2002). We compared the ﬁt of
wo nested site speciﬁc models to the data – a neutral model that
oes not admit positive selection (ω ≤1) and an alternative model
hat admits positive selection (ω >1). We compared models M0 to
3, M1a to M2a, M7 to M8 and M8a to M8. In the ﬁrst comparison,
he model M0 assumes a constant ω ratio across the genes whereas
3 assumes different proportions of discrete classes of sites with
ifferent ω ratios. In the second comparison the null model M1a
neutral/purifying model), was formulated to allow only two site
lasses for ω: the conserved category with 0<ω <1 and the neutral
ategory with ω =1. The alternative model, M2a (positive selection
F
e
l
p
uodel), allows a third category of sites, which has an ω >1. In the
ast two comparisons the neutralM7model assumes that ω follows
beta distribution with 10 categories, each corresponding to a dis-
inctive ω value that is always less than 1 while the also neutral
8a model, which is similar to the model M7, allows for an extra
lass of codons with ω =1. The alternative model, M8, has an extra
ategory with an ω >1 (more details of the models can be found in
ang et al., 2000 and Yang et al., 2005). To assess whether allowing
odons to evolve under positive selection gives a signiﬁcantly bet-
er ﬁt to the data, the log likelihood values for each pair of nested
odels were compared using a likelihood ratio test (LRT). The level
f signiﬁcance for these LRTs was performed using four degrees of
reedom for the comparison between models M0–M3, two degrees
f freedom in both comparisons between M1a–M2a and M7–M8
nd one degree of freedom for the comparison M8a–M8. Simu-
ations were run three times with multiple starting values for ω.
inally, the empirical Bayesmethod (Nielsen and Yang, 1998;Wong
t al., 2004) was used to determine which amino acids were most
ikely responsible for the signature of positive selection. Sites with
osterior probabilities >0.95were considered likely to have evolved
nder adaptive evolution.
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Table 2
Likelihood ratio statistics (2l) for comparison of different models of codon evolu-
tion at the major capsid gene VP60 of RHDV
Comparison 2l d.f.a Signiﬁcance
M0 (one ratio) vs. M3 (discrete) 238.6 4 <0.001
M1a (nearly neutral) vs. M2a (selection) 2.0 2 >0.05
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47 (beta) vs. M8 (beta and ω) 22.4 2 <0.001
8a (beta and ω =1) vs. M8 (beta and ω) 4.0 1 <0.05
a Number of degrees of freedom used.
. Results and discussion
Evidence for positive selection on RHDV VP60 sequences was
etected using a ML method implemented in the software package
AML (Yang, 1997). We compared models that incorporate or pro-
ibit positive selection (Table 2). We found that the comparisons
0 to M3, M7 to M8 and M8a to M8 are signiﬁcant and models
ermitting positive selection are a better ﬁt to the data (Table 2,
igniﬁcance values in bold). The more conservative comparison,
1a to M2a was not signiﬁcant. In addition, all models allowing
or positive selection had a class of codons with ω values above 1.0.
herefore, we evaluated which amino acids are most likely respon-
ible for the non-neutral pattern detected. Three codons appear to
e under positive selection (posterior probabilities over 95%; the
esults are presented in Table 3 according to the models tested).
ositively selected codons (PSCs) were identiﬁed at three of the
ix regions of the VP60 protein (Table 4) with two of them in the
ypervariable regions C and E. The presence of PSCs within the E
egion is in accordance with indications that this region contains
he main antigenic determinants (Capucci et al., 1995, 1998; Neill,
N
t
n
m
g
able 3
ummary of parameter estimates and likelihood values of different models of codon evol
ested model pairs Log likelihood Parameter e
0 (one ratio): 1a −8043.7 ω =0.09
3 (discrete): 5a −7924.4 p0 = 0.90, p1
(ω0 = 0.03), (
1a (nearly neutral): 1a −7929.7 p0 = 0.94,(p1
(ω0 = 0.04), (
2a (positive selection): 3a −7928.7 p0 = 0.94, p1
(ω0 = 0.04), (
7 (beta): 2a −7937.0 p=0.10, q=0
8a (beta and ω =1) 3a −7927.8 p0 = 0.95, (p1
8 (beta and ω): 4a −7925.8 p0 = 0.98, (p1
nderlined numbers are evidence of positive selection.
a Number of free parameters in the ω distribution.
b Values in parentheses are not free parameters.
c Parameters p and q are the shape parameters of the beta distribution which underlies
d Codons inferred to be under selection at the 85% level. Numbers in bold refer to codon
able 4
haracteristics of the amino acid possibilities at the positively selected codons (PSCs) wit
osition Region Amino acid possibilities Po
07 C S Hy
G Hy
N Hy
32 E S Hy
N Hy
K Hy
76 F A Hy
S Hy
T Hych 137 (2008) 253–256 255
992; Seal, 1994). Also, for Feline calicivirus (FCV), both the C and E
egions of the capsidwere found to be exposed to positive selection
Coyne et al., 2007). In addition, in Norwalk virus, another mem-
er of the Caliciviridae family, the P2 subdomain, which in RHDV
how overlaps with the regions C and E, was proposed to contain
eterminants for strain speciﬁcity (Prasad et al., 1999), while the
locking of the region between amino acid residues 300 and 384
nhibited the binding of the virus capsid to cells (White et al., 1996).
he association between positive selection and antigenicity sug-
ests an immune-mediated mechanism for RHDV evolution. The
vidence of positive selection at other regions than the proposed to
ontain the antigenic determinants may indicate the existence of
ther antigenic determinants on themajor capsidprotein that stim-
late protective immune responses. Especially the regionCwhich is
ocatedon the surfaceof the capsid couldbe involved in interactions
ith host receptors.
Amino acid substitutions at the PSCs may impose changes in
he polarity or charge of the protein (Table 4). The polarity and
he charge of a protein are important for the protein structure
nd protein–protein interaction. Amino acid possibilities within
he positively selected site 432 showed changes only with respect
o charge, whereas the other positively selected amino acids are
eutral, but showed changes with respect to polarity.
Changes at the three PSCs can generate a putative N-
lycosylation site (Table 4). On average, there are seven to nine
-glycosylation sites found in VP60 of RHDV. N-linked glycosyla-
ion is one of the most common post-translational modiﬁcations in
ewly synthesised proteins and involves the attachment of a high
annose core to the amide nitrogen of an asparagines residue. N-
lycosylation allows viruses to increase surface diversity which is
ution for the major capsid gene VP60 of RHDV
stimatesb,c Positively selected codonsd
None
=0.09, (p2 = 0.01) Not allowed
ω1 = 0.50), ω2 = 1.88
=0.06) Not allowed
ω1 = 1)
=0.05, (p2 = 0.01) 305, 307, 432, 476
ω1 = 1), ω2 = 2.39
.92 Not allowed
=0.05) p=0.27, q=4.87 (ω =1) Not allowed
=0.02) p=0.19, q=2.69, ω =1.59 305, 307, 412, 425, 432, 476, 572
M7 and M8.
s with posterior probabilities over 95%.
h posterior probabilities >95% (model M8)
larity Charge Potential site of N-glycosylation
drophilic Neutral Yes
drophobic Neutral
drophilic Neutral
drophilic Neutral Yes
drophilic Neutral
drophilic Positive
drophobic Neutral Yes
drophilic Neutral
drophilic Neutral
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nowntoaffect infectivity, protein folding, tropism,proteolyticpro-
essing and immune evasion (reviewed in Vigerust and Shepherd,
007). Thus, alteration of a glycosylation site can affect virus sur-
ival and transmissibility. Several human viral pathogens including
hose causing AIDS, hepatitis, inﬂuenza and West Nile disease, take
dvantage of glycosylation to evade the host immune system and
o increase virulence (reviewed in Vigerust and Shepherd, 2007).
ite-directed mutagenic studies on other single-stranded positive-
ense RNA viruses revealed that the deletion of N-glycosylation
ites enhance the host immune response and decrease the viru-
ence (e.g. Liu et al., 2007; Sainz et al., 2008). Drugs that inhibit
iral N-glycosylation of the virus envelope are currently being
ested for preventing viral infection (e.g. Balzarini, 2007). Oneof the
HDV strains known to be non-pathogenic (RCV; GenBank acces-
ion number X96868; Capucci et al., 1996), differs from pathogenic
trains by missing amino acids 307 and 308, which determine one
f the predicted N-glycosylation sites. Position 307 was found to be
nder positive selection.
In conclusion, we provide evidence of positive selection at the
ajor capsid protein VP60 of RHDV. The results suggest that PSCs
end to be associated with known antigenic regions, indicating
hat viral variation is mainly driven by the host immune response.
ositively selected sites at other regions may indicate antigenic
eterminants yet to be discovered. Identifying these PSCs is impor-
ant, as this variation is likely to be related to pathogenicity and
irulence. However, virulence may be a multigenic trait with other
egions of the genome, that may not stimulate directly protec-
ive immune responses, also determining virulence (by controlling
eplication rate, proteolytic activity, etc.).
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